CHICAGO, IL and Nutley, NJ - January 13, 2001

Integrated Genomics, Inc. announced today it had signed a research and licensing agreement with Roche Vitamins Inc. (RVI) to perform work in the area of microbial genomics. Under the terms of the agreement, Integrated Genomics will sequence and analyze bacterial genomes that could lead to significant improvements in Roche's ability to produce vitamins, carotenoids and fine chemicals used in foods, pharmaceuticals, cosmetics and animal feeds. RVI will also license Integrated Genomics' genome analysis suite ERGO™.

CHICAGO, IL and Redwood City, CA - December 7, 2000

Maxygen, Inc. and Integrated Genomics, Inc. announced today that the companies have entered into a collaboration under the terms of which Maxygen will have access to Integrated Genomics' bioinformatics software and databases.

CHICAGO, IL - November 20, 2000

Integrated Genomics, Inc. announced today that its CEO, Michael Fonstein, PhD, is the winner of a coveted KPMG Illinois High Tech Award. Fonstein was recognized for his significant contributions to the advancement of high technology business, having brought innovative products, services, and jobs to Illinois.

CHICAGO, IL and Palo Alto, CA - June 18, 2000

Integrated Genomics, Inc. announced today it had signed a research and licensing agreement with Genencor International to perform work in the area of microbial genomics. Under the terms of the agreement, Integrated Genomics will analyze the bacterial genomes of interest to Genencor. Genencor will also license the Chicago-based company's genome analysis suite WIT-PRO™.

CHICAGO, IL and San Diego, CA - February 3, 2000

Integrated Genomics, Inc. (IG) announced today that it has entered into a research agreement with The Dow Chemical Company. Under the terms of agreement, Integrated Genomics will sequence and analyze genomes of interest to The Dow Chemical Company. Dow Chemical will also license IG's bioinformatics software package, WIT-PRO™, containing the largest genomic and biochemical databases in the market.

CHICAGO, IL (USA) and Burlington, Ontario (Canada) - January 21, 2000

CRS Robotics Corporation (TSE: ROB) is pleased to announce that it has completed the installation of an state-of-the-art, high throughput, fully automated DNA Purification System for Integrated Genomics, Inc. of Chicago, IL. Integrated Genomics will use the CRS custom designed system for automated plasmid isolation and purification of isolated DNA. DNA, a building block of life, is the main component of genes and the target of revolutionary research into cell function and scores of diseases including cancer, arthritis and diabetes.

CHICAGO, IL and Minneapolis, MN - July 22, 1999

Cargill, Inc. and Integrated Genomics, Inc. announced today a research and licensing agreement in the area of genomics of industrial microorganisms. Under the terms of the agreement, Integrated Genomics will sequence and analyze the genomes of microbial strains of interest to Cargill. Cargill will also license Integrated Genomics' bioinformatics tools, including the WIT-PRO™ genome analysis suite and biochemical and genomic databases.

CHICAGO, IL Indianapolis, IN - April 8, 1999

Dow AgroSciences LLC and Integrated Genomics Inc. today announced a multi-year research and licensing agreement that should lead to improved yields for spinosad, an innovative Dow AgroSciences product.

CHICAGO, IL - September 25, 1998

Integrated Genomics, Inc. (IG) announced today that it entered into a research collaboration with Midwest Research Institute which manages the National Renewable Energy Laboratory (NREL), for the U.S. Department of Energy, concerning the metabolic engineering of bacterial ethanol producer Zymomonas mobilis. Under the terms of the agreement, IG will provide NREL maps of certain metabolic pathways of Z. mobilis, as well as quantitative models of optimization of the strain's intermediary metabolism.

CHICAGO, IL and Research Triangle Park, NC - September 23, 1998

Integrated Genomics, Inc. (IG) announced today that it entered into a research collaboration with Glaxo Wellcome (NYSE: GLX), covering the development and licensing of metabolic bioinformatics software. Under the terms of the two-year agreement, Glaxo Wellcome will obtain access to EMP, the database of enzymatic reactions and pathways and to the query software being developed by IG.

CHICAGO, IL and Decatur, IL - August 3, 1998

Integrated Genomics, Inc. (IG), a Chicago-based biotechnology company, announced today that it has entered into a research agreement with Archer-Daniels-Midland Company of Decatur, IL. Under the terms of the agreement, IG will provide research services for ADM in the areas of IG expertise, including DNA sequencing and bioinformatics.